This content is machine translated Interdisciplinary care for skin cancer patients New drugs for the clinician What’s new in skin cancer therapy? An educational session at UniversitySpital Zurich focused on the options available to patients from improved immunotherapy and targeted treatments with BRAF and MEK inhibitors…
View Post 6 min This content is machine translated 4th Zurich Dermatology Training Days Regional dermatoses under the microscope At the Dermatological Training Days in Zurich, various regional dermatoses were presented on the basis of case histories: How do dermatoses of the ear, diseases of the mucous membranes and…
View Post 7 min This content is machine translated Abdominal wall sparing training after visceral surgical procedures Physical reconditioning and wound healing hand in hand Visceral surgery patient volumes have increased significantly in recent years. After major surgery with opening of the abdominal wall due to chronic, oncological or acute diseases, almost all patients suffer…
View Post 4 min This content is machine translated Metastatic colorectal cancer Comparison between bevacizumab and cetuximab in KRAS exon2 wild type. According to preliminary results of a large phase III trial presented at this year’s ASCO congress, bevacizumab and cetuximab (combined with FOLFOX or FOLFIRI) show similar efficacy in terms of…
View Post 4 min This content is machine translated Immuno-Oncology New pathways for improved cancer treatment? Long-term survival of patients with advanced-stage carcinoma is still an area where research is far from successful. In the field of melanoma, the approval of ipilimumab in 2011 has made…
View Post 4 min This content is machine translated Hype or hope? Metformin, vitamin D and aspirin as anticancer agents Time and again, various substances are praised as “anticancer agents,” both in scientific circles and in the lay press. A symposium at this year’s ASCO Congress in Chicago was dedicated…
View Post 5 min This content is machine translated Myeloproliferative neoplasms News from a field that is developing rapidly Classic myeloproliferative neoplasms (MPNs) include polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Several sessions at the EHA Congress in mid-June addressed the revision in the guidelines, news on JAK inhibition,…
View Post 6 min This content is machine translated Tumors in the head and neck area What does HPV infection mean for treatment? The incidence of tumors in the head and neck region is increasing. This is often caused by infections with the human papilloma virus 16 (HPV16). However, the prognosis of patients…
View Post 2 min This content is machine translated Gastric and esophageal cancer The scar heals, the questions remain As a therapist in oncology rehabilitation, I once encountered a patient who quoted her surgeon as saying, “I was able to remove your tumor completely. You are healthy again.” At…
View Post 4 min This content is machine translated Hemato-Oncology All hopes lie in targeted therapy What do so-called targeted therapies actually aim at? And what progress has been made in the various hematologic oncologic neoplasms in this regard? At the 21st Symposium Medicine in the…
View Post 4 min This content is machine translated Multiple Myeloma Active ingredients at a glance At the EHA Congress in Milan, multiple myeloma was the focus of several events. What are the current results of proteasome inhibitors and immunomodulatory drugs and what is their promise…
